- Trump recently signed the “Right To Try Act” giving terminally ill patients the right to use experimental medication.
- While they don’t need FDA approval (successful human clinical trials), these treatments must clear Phase 1 safe-use testing.
- Given that 38 states already have similar legislation, most experimental drugs are extremely expensive (not covered by insurance) and pharmaceutical companies are hesitant to offer experimental treatment (potential lawsuits), the new legislation changes little.
